Effects of anakinra monotherapy on joint damage in patients with rheumatoid arthritis. Extension of a 24-week randomized, placebo-controlled trial.

Source:http://linkedlifedata.com/resource/pubmed/id/15170922

Download in:

View as

General Info

PMID
15170922